Cancer Therapy and Oral Mucositis: An Appraisal of Drug Prophylaxis

Drug Safety

Volumn 9, Issue 3, 1993, Pages 185-195

  Verdi, Christopher J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; BENZYDAMINE; BETA CAROTENE; CHLORHEXIDINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PENTOXIFYLLINE; POLYMYXIN B; PROSTAGLANDIN E2; SILVER NITRATE; SUCRALFATE; TOBRAMYCIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; CRYOTHERAPY; CYTOTOXICITY; DRUG EFFICACY; HELIUM NEON LASER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORBIDITY; MOUTH MUCOSA; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; REVIEW; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ANTINEOPLASTIC AGENTS; HUMAN; MOUTH MUCOSA; STOMATITIS;

EID: 0027424011     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/00002018-199309030-00004     Document Type: Review

References (48)

1. Phase II trial of high-dose continuous infusion 5-fluorouracil with allopurinol modulation in colon cancer
2. Phase I–II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation
3. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
4. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity
5. 2
6. Conservative treatment of trophic skin ulcers with trental
7. Pentoxifylline inhibits interleukin-2-induced leukocyte-endothelial adherence and reduces systemic toxicity
8. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse
9. 2 for chronic leg ulcers
10. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse
11. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial
12. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
13. Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal
14. Hematopoietic growth factors: biology and clinical applications
15. Dexamethasone and pentoxifyl-line inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway
16. Modulation of 5-fluorouracil toxicity by allopurinol in man
17. Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy
18. Benzydamine HC1, a new agent for the treatment of radiation mucositis of the oropharynx
19. 2 enhances healing of chemotherapy-associated mucosal lesions
20. Research on the topical activity of benzydamine
21. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis
22. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer
23. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy
24. Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen
25. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis
26. Toxicity: ten years later
27. Pretreatment strategies for infection prevention in chemotherapy patients
28. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin’s lymphoma: a randomized controlled trial
29. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy: a randomized, double-blind cross-over study
30. 2 in patients with oral malignancies undergoing chemo- and radiotherapy
31. Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report
32. Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy
33. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil
34. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro
35. Aspects of the mechanisms of action of benzydamine
36. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis
37. Oral sucralfate suspension for mucositis
38. Benzydamine HC1 in the management of chemotherapy-induced mucositis: I. Pilot Study
39. Prevention and management of oral mucositis induced by antineoplastic therapy
40. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis
41. Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients
42. Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline
43. Does sucralfate affect the normal gastric mucosa? Histologic, ultrastructural, and functional assessment in the rat
44. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes
45. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse
46. A Phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial
47. The use of pentoxifylline (Trental 400) in the treatment of leg ulcers: results of a double-blind trial